Agate Pass Investment Management’s ResMed RMD Stock Holding History

Agate Pass Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,011	Closed	-$227K	–	113
2026 Q1	$227K	Hold	1,011	–	–	0.09%	99
2025 Q4	$244K	Hold	1,011	–	–	0.09%	98
2025 Q3	$277K	Sell	1,011 -42	-4%	-$11.5K	0.11%	99
2025 Q2	$272K	Hold	1,053	–	–	0.11%	102
2025 Q1	$236K	Hold	1,053	–	–	0.1%	104
2024 Q4	$241K	Hold	1,053	–	–	0.11%	103
2024 Q3	$257K	Hold	1,053	–	–	0.13%	90
2024 Q2	$202K	Sell	1,053 -85	-7%	-$17.2K	0.11%	93
2024 Q1	$225K	Buy	+1,138	New	+$209K	0.12%	92
2023 Q3	–	Sell	-1,086	Closed	-$237K	–	91
2023 Q2	$237K	Sell	1,086 -130	-11%	-$29K	0.14%	88
2023 Q1	$266K	Hold	1,216	–	–	0.17%	86
2022 Q4	$253K	Hold	1,216	–	–	0.18%	86
2022 Q3	$265K	Hold	1,216	–	–	0.2%	85
2022 Q2	$255K	Hold	1,216	–	–	0.18%	89
2022 Q1	$295K	Hold	1,216	–	–	0.18%	85
2021 Q4	$317K	Buy	+1,216	New	+$316K	0.2%	84

Other funds holding RMD

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

CISOA

Capital Investment Services of America Milwaukee, Wisconsin $1.02B AUM 3.04% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

Agate Pass Investment Management's RMD Position: Q2 2026 in Review

Agate Pass Investment Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,011 shares — an estimated $227K sold.

Agate Pass Investment Management first reported a position in RMD in Q4 2021 and held it in 16 quarters. The position peaked at $317K in Q4 2021. 151 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Agate Pass Investment Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Agate Pass Investment Management sold 1,011 ResMed shares in Q2 2026, an estimated $227K.
Agate Pass Investment Management first reported a position in ResMed in Q4 2021 and held it in 16 quarters.
Agate Pass Investment Management's ResMed position peaked at $317K in Q4 2021.
151 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Agate Pass Investment Management's 13F filing for Q2 2026, filed 8 Jul 2026.